Coronavirus Vaccine in the U.S.
Superforecasters see a 53% probability that 25 million doses of an FDA-approved COVID-19 vaccine will be available by March 2021 vs. 69% two weeks ago.
Image: Goldman Sachs Global Investment Research
Superforecasters see a 53% probability that 25 million doses of an FDA-approved COVID-19 vaccine will be available by March 2021 vs. 69% two weeks ago.
Image: Goldman Sachs Global Investment Research